A/S, a global healthcare giant specializing in diabetes care and obesity treatment, continues to dominate the GLP-1 drug market alongside competitor Eli Lilly (NYSE:LLY). With a market capitalization ...

particularly as the NHS began offering Wegovy in late 2023 and will start offering Mounjaro to patients in March 2025. There has also been a surge in demand for weight loss jabs after a number of ...

The National Pharmacy Association (NPA) has written to regulators calling for tougher rules to be introduced around sale of weight loss jabs online.

What foods to eat and avoid for optimal results. Whether you've been prescribed Mounjaro (tirzepatide) for type 2 diabetes, ...